Nanalysis Revenue and Competitors
Estimated Revenue & Valuation
- Nanalysis's estimated annual revenue is currently $14.3M per year.
- Nanalysis's estimated revenue per employee is $213,150
- Nanalysis's total funding is $28.3M.
- Nanalysis has 67 Employees.
- Nanalysis grew their employee count by 18% last year.
Nanalysis Competitors & Alternatives
|Competitor Name||Revenue||Number of Employees||Employee Growth||Total Funding||Valuation|
What Is Nanalysis?
Nanalysis Scientific Corp. is a public company (TSXV:NSCI, FRA:1N1, OTCMKTS:NSCIF). The company is a global manufacturer and seller of compact Nuclear Magnetic Resonance (NMR) spectrometers. The NMReady-60ￃﾢ￢ﾀﾞￂﾢ was the first portable, high-resolution 60 MHz benchtop NMR spectrometer released in the market in 2013. These instruments are notable for their ease of use, low-maintenance, accessibility, affordability and automatability. In 2019, Nanalysis introduced the 100 MHz spectrometer, representing the highest resolution instrument available on the market. Designed with flexibility in mind, the instruments can be configured as traditional NMR spectrometers or programmed as analyzers for specific industrial applications (oil and gas, chemical, pharma, biotech, food science, atomic agencies, cannabis, mining). The company has sold instruments in over 45 countries and is expanding our North American sales team. Nanalysis' benchtop NMR technology has been widely recognized, including being named Company of the Year in Global Portable NMR in the prestigious Frost & Sullivan award for three consecutive years. In 2020 Nanalysis expanded its portfolio of magnetic resonance technology acquiring RS2D and their superior camelon 4 technology offering their high-field NMR pulse console (200-600MHz), preclinical MRI and MRI product line.keywords:N/A
Number of Employees
Employee Growth %
Nanalysis logo (CNW Group/Nanalysis Scientific Corp.) Investors interested in participating on the live call can...
Nanalysis devices are used in many industries (oil and gas, chemical, mining, pharma, biotech, flavor and fragrances, agrochemicals, law...
/C O R R E C T I O N from Source -- Nanalysis Scientific Corp./. April 13, 2022 ·4 min read. In this article: NSCIF. Recommendation Rating.
CALGARY, AB, Aug. 25, 2021 /CNW/ - Nanalysis Scientific Corp. Nanalysis Scientific Corp. ("the Company"), (TSXV: NSCI) (OTCQX: NSCIF) (FRA: 1N1), announces it has closed the previously-announced underwritten public offering (the "Public Offering") of units (the "Units") of the Company and the co ...
/NOT FOR DISTRIBUTION TO THE U.S. NEWSWIRE OR FOR DISSEMINATION IN THE UNITED STATES/ CALGARY, AB, July 29, 2021 /CNW/ - (the "Company" or "Nanalysis"), (TSXV: NSCI) (OTCQX: NSCIF) (FRA: 1N1) is pleased to announce that it has entered into an agreement with a syndicate of underwriters led by Ec ...
|Company Name||Revenue||Number of Employees||Employee Growth||Total Funding|